290 related articles for article (PubMed ID: 10912793)
1. Activation of mitogen-activated protein kinases is required for alpha1-adrenergic agonist-induced cell scattering in transfected HepG2 cells.
Spector M; Nguyen VA; Sheng X; He L; Woodward J; Fan S; Baumgarten CM; Kunos G; Dent P; Gao B
Exp Cell Res; 2000 Jul; 258(1):109-20. PubMed ID: 10912793
[TBL] [Abstract][Full Text] [Related]
2. Alpha-adrenergic inhibition of proliferation in HepG2 cells stably transfected with the alpha1B-adrenergic receptor through a p42MAPkinase/p21Cip1/WAF1-dependent pathway.
Auer KL; Spector MS; Tombes RM; Seth P; Fisher PB; Gao B; Dent P; Kunos G
FEBS Lett; 1998 Sep; 436(1):131-8. PubMed ID: 9771908
[TBL] [Abstract][Full Text] [Related]
3. Involvement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase in alpha1B-adrenergic receptor/Galphaq-induced inhibition of cell proliferation.
Yamauchi J; Itoh H; Shinoura H; Miyamoto Y; Hirasawa A; Kaziro Y; Tsujimoto G
Biochem Biophys Res Commun; 2001 Mar; 281(4):1019-23. PubMed ID: 11237765
[TBL] [Abstract][Full Text] [Related]
4. alpha(1B)- and alpha(1D)-Adrenergic receptors exhibit different requirements for agonist and mitogen-activated protein kinase activation to regulate growth responses in rat 1 fibroblasts.
Waldrop BA; Mastalerz D; Piascik MT; Post GR
J Pharmacol Exp Ther; 2002 Jan; 300(1):83-90. PubMed ID: 11752101
[TBL] [Abstract][Full Text] [Related]
5. Regulation of p42/p44 MAPK and p38 MAPK by the adenosine A(1) receptor in DDT(1)MF-2 cells.
Robinson AJ; Dickenson JM
Eur J Pharmacol; 2001 Feb; 413(2-3):151-61. PubMed ID: 11226388
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of the p38 mitogen-activated protein kinase by SB 203580 blocks PMA-induced Mr 92,000 type IV collagenase secretion and in vitro invasion.
Simon C; Goepfert H; Boyd D
Cancer Res; 1998 Mar; 58(6):1135-9. PubMed ID: 9515796
[TBL] [Abstract][Full Text] [Related]
7. Activation of mitogen-activated protein kinases (p38-MAPKs, SAPKs/JNKs and ERKs) by the G-protein-coupled receptor agonist phenylephrine in the perfused rat heart.
Lazou A; Sugden PH; Clerk A
Biochem J; 1998 Jun; 332 ( Pt 2)(Pt 2):459-65. PubMed ID: 9601075
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of 46 and 54 kDa jun N-terminal kinases and p38 mitogen-activated protein kinase by human alpha(1A)-adrenoceptors expressed in Rat-1 cells.
Alexandrov A; Keffel S; Goepel M; Michel MC
Biochem Biophys Res Commun; 1999 Aug; 261(2):372-6. PubMed ID: 10425192
[TBL] [Abstract][Full Text] [Related]
9. Involvement of a phosphatidylinositol 3-kinase-p38 mitogen activated protein kinase pathway in antigen-induced IL-4 production in mast cells.
Hirasawa N; Sato Y; Fujita Y; Ohuchi K
Biochim Biophys Acta; 2000 Jan; 1456(1):45-55. PubMed ID: 10611455
[TBL] [Abstract][Full Text] [Related]
10. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
Aoki H; Richmond M; Izumo S; Sadoshima J
Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
[TBL] [Abstract][Full Text] [Related]
11. Activation of the p38 and p42/p44 mitogen-activated protein kinase families by the histamine H(1) receptor in DDT(1)MF-2 cells.
Robinson AJ; Dickenson JM
Br J Pharmacol; 2001 Aug; 133(8):1378-86. PubMed ID: 11498525
[TBL] [Abstract][Full Text] [Related]
12. Activated Ki-Ras suppresses 12-O-tetradecanoylphorbol-13-acetate-induced activation of the c-Jun NH2-terminal kinase pathway in human colon cancer cells.
Okumura K; Shirasawa S; Nishioka M; Sasazuki T
Cancer Res; 1999 May; 59(10):2445-50. PubMed ID: 10344756
[TBL] [Abstract][Full Text] [Related]
13. The role of JNK and p38 MAPK activities in UVA-induced signaling pathways leading to AP-1 activation and c-Fos expression.
Silvers AL; Bachelor MA; Bowden GT
Neoplasia; 2003; 5(4):319-29. PubMed ID: 14511403
[TBL] [Abstract][Full Text] [Related]
14. Distinct roles for p42/p44 and p38 mitogen-activated protein kinases in the induction of IL-2 by IL-1.
Matthews JS; O'Neill LA
Cytokine; 1999 Sep; 11(9):643-55. PubMed ID: 10479400
[TBL] [Abstract][Full Text] [Related]
15. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
Ishikawa Y; Kitamura M
Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
[TBL] [Abstract][Full Text] [Related]
16. Conditional expression of the mitogen-activated protein kinase (MAPK) phosphatase MKP-1 preferentially inhibits p38 MAPK and stress-activated protein kinase in U937 cells.
Franklin CC; Kraft AS
J Biol Chem; 1997 Jul; 272(27):16917-23. PubMed ID: 9202001
[TBL] [Abstract][Full Text] [Related]
17. [The role of mitogen-activated protein kinase cascades in inhibition of proliferation in human prostate carcinoma cells by raloxifene: an in vitro experiment].
Zhang YX; Kong CZ
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(4):271-5. PubMed ID: 18361842
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of thrombin-induced MAPK activation associated with cell proliferation in human cultured tracheal smooth muscle cells.
Lin CC; Shyr MH; Chien CS; Wang CC; Chiu CT; Hsiao LD; Yang CM
Cell Signal; 2001 Apr; 13(4):257-67. PubMed ID: 11306243
[TBL] [Abstract][Full Text] [Related]
19. p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages.
Chen CC; Wang JK
Mol Pharmacol; 1999 Mar; 55(3):481-8. PubMed ID: 10051531
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway.
Tanaka Y; Gavrielides MV; Mitsuuchi Y; Fujii T; Kazanietz MG
J Biol Chem; 2003 Sep; 278(36):33753-62. PubMed ID: 12824193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
